My Baby Was Diagnosed with Noonan Syndrome
The short answer
Noonan syndrome is a genetic condition occurring in about 1 in 1,000-2,500 births, caused by mutations in genes of the RAS-MAPK pathway. It affects multiple body systems and is characterized by distinctive facial features, short stature, heart defects (most commonly pulmonary valve stenosis), and varying degrees of developmental delay. While Noonan syndrome is a lifelong condition, the wide range of severity means that many people with Noonan syndrome lead independent, fulfilling lives. Early intervention and comprehensive medical care significantly improve outcomes.
Thousands of parents search for this exact thing. You are not alone.
By Age
What to expect by age
0-6 months
In infancy, common features include distinctive facial appearance (widely-spaced eyes, low-set ears, deep philtrum), excess nuchal skin or cystic hygroma history, feeding difficulties (poor suck, reflux), and heart defects. A cardiac evaluation (echocardiogram) is one of the first priorities. Feeding challenges are common and may require occupational therapy or specialized nipples. Genetic testing confirms the diagnosis. About 50-80% of cases involve the PTPN11 gene.
6-12 months
Motor development may be delayed — sitting and crawling often come later than expected. Early intervention services (physical therapy, occupational therapy, feeding therapy) should begin as soon as developmental concerns are identified. Growth is typically below average, and your pediatrician will use Noonan syndrome-specific growth charts. Hearing and vision should be checked, as both can be affected.
1-3 years
Language development may be delayed, and speech therapy is often beneficial. Cognitive ability varies widely — some children are in the normal range, while others have mild to moderate intellectual disability. Behavioral concerns like attention difficulties and social challenges may emerge. Your child's developmental pediatrician can help coordinate therapies. Bleeding tendencies (due to clotting factor deficiencies) should be evaluated before any surgical procedures.
3 years+
With appropriate support, many children with Noonan syndrome thrive in school. Short stature may be addressed with growth hormone therapy, which is FDA-approved for Noonan syndrome. Puberty may be delayed. Ongoing cardiac monitoring is important, as some heart issues can progress or new ones can develop. A multidisciplinary approach — cardiology, endocrinology, genetics, developmental pediatrics — provides the best outcomes.
What Should You Do?
When to take action
- Your baby with Noonan syndrome is receiving appropriate cardiac monitoring and developmental support
- Your baby is making progress with feeding and developmental milestones, even if at a slower pace
- Genetic testing has confirmed the diagnosis and you have a care team in place
- Your baby with Noonan syndrome is having significant feeding difficulties or poor weight gain
- You notice your baby bruises very easily or bleeds for a long time from minor injuries
- Developmental milestones are significantly delayed beyond what your care team expected
- You have concerns about your baby's heart or breathing
- Your baby has difficulty breathing, turns blue, or seems to tire excessively during feeds — this may indicate a cardiac issue requiring urgent evaluation
- Your baby has unusual or excessive bleeding that does not stop — seek emergency care
- Your baby has a seizure or sudden change in alertness — call 911
Sources
Related Resources
Trust your instincts. If something feels wrong, reach out to your pediatrician.
Worrying about your baby means you care. That is a good thing.
Related Medical Concerns
My Baby Was Diagnosed with 22q11.2 Deletion Syndrome (DiGeorge)
22q11.2 deletion syndrome (also known as DiGeorge syndrome or velocardiofacial syndrome) is caused by a small missing piece of chromosome 22 and is the most common microdeletion syndrome, affecting about 1 in 4,000 births. It can affect many body systems — heart, immune system, palate, calcium regulation, learning, and behavior. The severity varies widely, even within the same family. Some children have significant medical needs, while others have mild features. With appropriate monitoring and support, many people with 22q11.2 deletion syndrome lead fulfilling, independent lives.
My Baby Was Diagnosed with Beckwith-Wiedemann Syndrome
Beckwith-Wiedemann syndrome (BWS) is an overgrowth disorder affecting approximately 1 in 10,500 births. It is caused by changes in gene regulation on chromosome 11p15. Common features include macrosomia (large body size), macroglossia (large tongue), abdominal wall defects (omphalocele or umbilical hernia), ear creases or pits, and neonatal hypoglycemia. The most important medical consideration is an increased risk of certain childhood cancers (particularly Wilms tumor and hepatoblastoma), which requires regular screening through early childhood. With appropriate monitoring, the prognosis for children with BWS is generally very good.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
How to Advocate for Your Child's Needs
You know your child better than anyone, and your observations matter. If you feel something is not right with your child's development or health, you have every right to ask questions, request evaluations, and seek second opinions. Advocating for your child is not being difficult - it is being a good parent.